Results 131 to 140 of about 10,807 (177)
Some of the next articles are maybe not open access.
CLINICAL TRIAL OF A NEW NITROGEN-MUSTARD COMPOUND
The Lancet, 1956C, SELLEI +3 more
openaire +2 more sources
Mutagenicity of heterocyclic nitrogen mustards (ICR compounds) in cultured mammalian cells.
Cancer research, 1978The mutagenicity of six heterocylic nitrogen mustards (ICR compounds) has been determined in a cultured mammalian cell system by use of resistance to the purine analog 6-thioguanine to select for mutation induction at the hypoxanthine-guanine phosphoribosyltransferase locus in Chinese hamster ovary cells. The six compounds tested are ICR 191, 170, 292,
J P, O'Neill, J C, Fuscoe, A W, Hsie
openaire +1 more source
Comparative Therapeutic Activity of the Nitrogen Mustards and Allied Compounds
Medical Clinics of North America, 1956M P, SYKES +2 more
openaire +2 more sources
A comparison of the effects of various nitrogen mustard compounds on embryonic cells
Journal of Experimental Zoology, 1948D, BODENSTEIN, A, GOLDIN
openaire +2 more sources
A TECHNIQUE FOR INTRAPLEURAL ADMINISTRATION OF NITROGEN MUSTARD COMPOUNDS
The American Journal of the Medical Sciences, 1957openaire +2 more sources
201. Some compounds related to the aromatic “nitrogen mustards.”
J. Chem. Soc., 1950George A. R. Kon, John J. Roberts
openaire +1 more source
Specific developmental inhibitions produced in amphibian embryos by a nitrogen mustard compound
Journal of Experimental Zoology, 1946R, GILLETTE, D, BODENSTEIN
openaire +2 more sources
THE TOXICITY AND PHARMACOLOGICAL ACTION OF THE NITROGEN MUSTARDS AND CERTAIN RELATED COMPOUNDS
The Journal of Pharmacology and Experimental Therapeutics, 1947WILLIAM P. ANSLOW +3 more
openaire +1 more source
[Clinical trials with nitrogen mustard compounds].
Archivos uruguayos de medicina, cirugia y especialidades, 2004M, FERRARI, N, PENCO
openaire +1 more source

